Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S. and Ross, S. 2020. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J. Psychopharmacol. 34, 155-166. Andrews, T. and Wright, K. 2022. The frontiers of new psychedelic therapies: A survey of sociological themes and issues. Sociol. Compass 16, 12959. Becker, A. M., Holze, F., Grandinetti, T., Klaiber, A., Toedtli, V. E., Kolaczynska, K. E., Duthaler, U., Varghese, N., Eckert, A., Grünblatt, E. and Liechti, M. E. 2022. Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Clin. Pharmacol. Ther. 111, 886-895. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S. and Krystal, J. H. 2000. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354. Bogenschutz, M. P. and Ross, S. 2018. Therapeutic applications of classic hallucinogens. Curr. Top. Behav. Neurosci. 36, 361-391.